泌尿系统疾病患者血脂异常与前列腺癌的风险

A. Smirnov, O. Gruzdeva, E. Pomeshkin, A. I. Bragin-Maltsev
{"title":"泌尿系统疾病患者血脂异常与前列腺癌的风险","authors":"A. Smirnov, O. Gruzdeva, E. Pomeshkin, A. I. Bragin-Maltsev","doi":"10.23946/2500-0764-2022-7-1-42-52","DOIUrl":null,"url":null,"abstract":"Aim. To assess the impact of homeostasis parameters on risk of prostate cancer.Materials and Methods. The study included 108  patients with urologic diseases and with (n = 54) or without (n = 54) prostate cancer. Median age in both groups was 67 (interquartile range 64-73) years. Clinicopathological data and blood test results have been collected from outpatient and inpatient records. In particular, we measured serum levels of total testosterone and prostate-specific antigen.Results. Risk factors for prostate cancer include increased total cholesterol (p = 0.023), low-density lipoprotein cholesterol (p = 0.035), total triglycerides (p = 0.048), and total testosterone (p = 0.002). High levels of total testosterone directly correlated with the tumor stage (r = 0.56). The concentration of prostate-specific antigen correlated with the lipid parameters and remained a reliable diagnostic criterion (p = 0.002).Conclusion. The association of hyper/dyslipidemia with prostate cancer provides an opportunity to improve its prevention by routine lipid screening in high-risk groups.","PeriodicalId":12493,"journal":{"name":"Fundamental and Clinical Medicine","volume":"33 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-03-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Dyslipidemia and risk of prostate canсer in patients with urologic diseases\",\"authors\":\"A. Smirnov, O. Gruzdeva, E. Pomeshkin, A. I. Bragin-Maltsev\",\"doi\":\"10.23946/2500-0764-2022-7-1-42-52\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Aim. To assess the impact of homeostasis parameters on risk of prostate cancer.Materials and Methods. The study included 108  patients with urologic diseases and with (n = 54) or without (n = 54) prostate cancer. Median age in both groups was 67 (interquartile range 64-73) years. Clinicopathological data and blood test results have been collected from outpatient and inpatient records. In particular, we measured serum levels of total testosterone and prostate-specific antigen.Results. Risk factors for prostate cancer include increased total cholesterol (p = 0.023), low-density lipoprotein cholesterol (p = 0.035), total triglycerides (p = 0.048), and total testosterone (p = 0.002). High levels of total testosterone directly correlated with the tumor stage (r = 0.56). The concentration of prostate-specific antigen correlated with the lipid parameters and remained a reliable diagnostic criterion (p = 0.002).Conclusion. The association of hyper/dyslipidemia with prostate cancer provides an opportunity to improve its prevention by routine lipid screening in high-risk groups.\",\"PeriodicalId\":12493,\"journal\":{\"name\":\"Fundamental and Clinical Medicine\",\"volume\":\"33 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-03-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Fundamental and Clinical Medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.23946/2500-0764-2022-7-1-42-52\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Fundamental and Clinical Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.23946/2500-0764-2022-7-1-42-52","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

摘要

的目标。评估体内平衡参数对前列腺癌风险的影响。材料与方法。该研究包括108例泌尿系统疾病患者,伴有或未伴有前列腺癌(n = 54)。两组患者的中位年龄均为67岁(四分位数范围64-73岁)。从门诊和住院记录中收集了临床病理资料和血液检查结果。特别地,我们测量了血清总睾酮和前列腺特异性抗原的水平。前列腺癌的危险因素包括总胆固醇(p = 0.023)、低密度脂蛋白胆固醇(p = 0.035)、总甘油三酯(p = 0.048)和总睾酮(p = 0.002)升高。总睾酮水平高与肿瘤分期直接相关(r = 0.56)。前列腺特异性抗原浓度与血脂参数相关,仍然是可靠的诊断标准(p = 0.002)。高/血脂异常与前列腺癌的关系为在高危人群中通过常规脂质筛查提高预防前列腺癌提供了机会。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Dyslipidemia and risk of prostate canсer in patients with urologic diseases
Aim. To assess the impact of homeostasis parameters on risk of prostate cancer.Materials and Methods. The study included 108  patients with urologic diseases and with (n = 54) or without (n = 54) prostate cancer. Median age in both groups was 67 (interquartile range 64-73) years. Clinicopathological data and blood test results have been collected from outpatient and inpatient records. In particular, we measured serum levels of total testosterone and prostate-specific antigen.Results. Risk factors for prostate cancer include increased total cholesterol (p = 0.023), low-density lipoprotein cholesterol (p = 0.035), total triglycerides (p = 0.048), and total testosterone (p = 0.002). High levels of total testosterone directly correlated with the tumor stage (r = 0.56). The concentration of prostate-specific antigen correlated with the lipid parameters and remained a reliable diagnostic criterion (p = 0.002).Conclusion. The association of hyper/dyslipidemia with prostate cancer provides an opportunity to improve its prevention by routine lipid screening in high-risk groups.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信